Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Dec 9.
Published in final edited form as: Cancer Metastasis Rev. 2024 Nov 26;44(1):7. doi: 10.1007/s10555-024-10229-z

Retraction Note: EET signaling in cancer

Dipak Panigrahy 1, Emily R Greene 1, Ambra Pozzi 2, Dao Wen Wang 3, Darryl C Zeldin 4
PMCID: PMC11626418  NIHMSID: NIHMS2039824  PMID: 39589597

The Editor in Chief has retracted this article because Figure 1 and 3, as well as large part of the text were duplicate from a previously published article by some of the same authors [1]. This article is therefore redundant.

All authors agree to this retraction.

Footnotes

Retraction Note: Cancer and Metastasis Reviews (2011) 30:525–540 https://doi.org/10.1007/s10555-011-9315-y

The original article can be found online at https://doi.org/10.1007/s10555-011-9315-y.

Reference

  • 1.Panigrahy D, Kaipainen A, Greene ER, et al. (2010). Cytochrome P450-derived eicosanoids: The neglected pathway in cancer. Cancer and Metastasis Reviews, 29, 723–735. 10.1007/s10555-010-9264-x [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES